Literature DB >> 1349897

Extensive allelic variation in Cryptococcus neoformans.

A Casadevall1, L F Freundlich, L Marsh, M D Scharff.   

Abstract

The orotidine monophosphate pyrophosphorylase (OMPPase) gene locus of the DNA of 13 Cryptococcus neoformans var. neoformans strains, including 10 recent clinical isolates, was studied by using restriction fragment length polymorphisms and nucleotide sequence analysis. The OMPPase locus (URA5) is highly polymorphic, and at least six alleles were identified. The nucleotide sequences of some alleles differed by up to 5%. The majority of the nucleotide polymorphisms in the protein-coding region occurred at the third codon position and were silent. The low frequency of replacement nucleotide substitutions relative to silent nucleotide substitutions implied that there is strong selection against amino acid changes in OMPPase. The allelic variation suggested that there is extensive genomic diversity among C. neoformans clinical isolates from one geographic area. The various alleles are potentially useful markers in the study of the population structure, epidemiology, and pathogenesis of C. neoformans strains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349897      PMCID: PMC265228          DOI: 10.1128/jcm.30.5.1080-1084.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans.

Authors:  A Varma; K J Kwon-Chung
Journal:  J Gen Microbiol       Date:  1989-12

2.  Nucleotide sequences of the gnd genes from nine natural isolates of Escherichia coli: evidence of intragenic recombination as a contributing factor in the evolution of the polymorphic gnd locus.

Authors:  M Bisercić; J Y Feutrier; P R Reeves
Journal:  J Bacteriol       Date:  1991-06       Impact factor: 3.490

3.  Serotypes of Cryptococcus neoformans in patients with AIDS.

Authors:  M G Rinaldi; D J Drutz; A Howell; M A Sande; C B Wofsy; W K Hadley
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

4.  Are eukaryotic microorganisms clonal or sexual? A population genetics vantage.

Authors:  M Tibayrenc; F Kjellberg; J Arnaud; B Oury; S F Brenière; M L Dardé; F J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

5.  A new genus, filobasidiella, the perfect state of Cryptococcus neoformans.

Authors:  K J Kwon-Chung
Journal:  Mycologia       Date:  1975 Nov-Dec       Impact factor: 2.696

6.  A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes.

Authors:  K J Kwon-Chung
Journal:  Mycologia       Date:  1976 Jul-Aug       Impact factor: 2.696

7.  Cloning of 18S and 25S rDNAs from the pathogenic fungus Cryptococcus neoformans.

Authors:  B I Restrepo; A G Barbour
Journal:  J Bacteriol       Date:  1989-10       Impact factor: 3.490

8.  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.

Authors:  S L Chuck; M A Sande
Journal:  N Engl J Med       Date:  1989-09-21       Impact factor: 91.245

Review 9.  Ecology, life cycle, and infectious propagule of Cryptococcus neoformans.

Authors:  D H Ellis; T J Pfeiffer
Journal:  Lancet       Date:  1990-10-13       Impact factor: 79.321

10.  Rapid genetic identification and mapping of enzymatically amplified ribosomal DNA from several Cryptococcus species.

Authors:  R Vilgalys; M Hester
Journal:  J Bacteriol       Date:  1990-08       Impact factor: 3.490

View more
  35 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure.

Authors:  S P Franzot; J S Hamdan; B P Currie; A Casadevall
Journal:  J Clin Microbiol       Date:  1997-09       Impact factor: 5.948

3.  PCR-restriction fragment length polymorphism analysis of the phospholipase B (PLB1) gene for subtyping of Cryptococcus neoformans isolates.

Authors:  G Nicolas Latouche; Matthew Huynh; Tania C Sorrell; Wieland Meyer
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792

4.  Molecular epidemiology of clinical Cryptococcus neoformans strains from India.

Authors:  N Jain; B L Wickes; S M Keller; J Fu; A Casadevall; P Jain; M A Ragan; U Banerjee; B C Fries
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

5.  Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains.

Authors:  J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Molecular subtype distribution of Cryptococcus neoformans in four areas of the United States. Cryptococcal Disease Active Surveillance Group.

Authors:  M E Brandt; L C Hutwagner; L A Klug; W S Baughman; D Rimland; E A Graviss; R J Hamill; C Thomas; P G Pappas; A L Reingold; R W Pinner
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

7.  The gene encoding phosphoribosylaminoimidazole carboxylase (ADE2) is essential for growth of Cryptococcus neoformans in cerebrospinal fluid.

Authors:  J R Perfect; D L Toffaletti; T H Rude
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole.

Authors:  A Casadevall; E D Spitzer; D Webb; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

9.  Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine.

Authors:  Y Wang; A Casadevall
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

10.  Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans.

Authors:  J K Lodge; E Jackson-Machelski; D L Toffaletti; J R Perfect; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.